Diagnosis and Treatment of Cholecystitis
The recommended approach for diagnosing cholecystitis requires a combination of detailed history, physical examination, laboratory tests, and imaging investigations, with ultrasound being the first-line imaging modality, followed by early laparoscopic cholecystectomy as the definitive treatment for most patients. 1
Diagnostic Approach
Clinical Evaluation
- No single clinical or laboratory finding has sufficient diagnostic power to establish or exclude acute cholecystitis, making a multi-modal approach necessary 1
- Key clinical findings include:
Laboratory Tests
- Elevated white blood cell count 1
- Elevated C-reactive protein 1
- Mildly elevated liver function tests may be present but are not specific 3
- Neutrophil count has shown the strongest association with acute cholecystitis in multivariate analysis (70% sensitivity, 65.8% specificity) 1
Imaging Studies
- Ultrasound is the first-line imaging modality with approximately 81% sensitivity and 83% specificity 4
- When ultrasound results are inconclusive, hepatobiliary iminodiacetic acid (HIDA) scan is the gold standard diagnostic test 4, 5
- Non-visualization of the gallbladder within 60 minutes indicates cystic duct obstruction (80-90% sensitivity) 1
- CT scan may be useful in complicated cases or when other diagnoses are being considered 6
Treatment Approach
Medical Management
- Initial management includes:
Surgical Management
- Early laparoscopic cholecystectomy (within 1-3 days of diagnosis) is the preferred treatment 4
- Laparoscopic cholecystectomy is recommended during all trimesters of pregnancy 4
- For elderly patients (>65 years), laparoscopic cholecystectomy is associated with lower 2-year mortality (15.2%) compared to non-operative management (29.3%) 4
Alternative Treatments for High-Risk Patients
- Percutaneous cholecystostomy tube placement may be considered for patients with exceptionally high perioperative risk 4
- However, this approach is associated with higher rates of postprocedural complications (65%) compared to laparoscopic cholecystectomy (12%) 4
- For acalculous cholecystitis, percutaneous drainage should be reserved only for severely ill patients 4, 5
Special Considerations
Risk Assessment for Common Bile Duct Stones (CBDS)
- Patients should be stratified for risk of CBDS according to clinical, laboratory, and imaging findings 1
- High-risk patients (evidence of CBDS on ultrasound or ascending cholangitis) should undergo preoperative ERCP 1
- Moderate-risk patients should undergo second-level examinations such as MRCP, EUS, or intraoperative cholangiography 1
Atypical Presentations
- Acute cholecystitis may present with atypical symptoms, especially in immunocompromised patients 2, 3
- Absence of typical findings (fever, leukocytosis, positive Murphy's sign) does not rule out cholecystitis 3
- In cases with high clinical suspicion despite normal ultrasound, HIDA scan should be considered 3, 5
Common Pitfalls
- Relying on a single clinical or laboratory finding for diagnosis 1
- Murphy's sign may be absent in patients who have received pain medication 2
- Ultrasound alone may miss the diagnosis in some cases, necessitating additional imaging 3, 6
- Delaying surgical intervention beyond 3 days is associated with worse outcomes 4
- Overlooking the possibility of common bile duct stones, which require specific management 1